In sponge exudates, it remains active at the site of wounds for several hours (Tkalcevic et al., 2007)
In its lawsuit, the OFA said that the FDAs decision to end the shortage was a reckless and arbitrary move and could deprive patients of a vital treatment for type 2 diabetes and obesity. In an interview with BioSpace last month, David Rosen, partner at Foley & Lardner, said that the lawsuit is a precedent in this area. Prior to the OFA suit, no one has ever challenged the FDAs decision to remove a therapy from the drug shortage list. The OFA case is still ongoing, with the next court update due on Thursday
We have convenient locations in Fort Lauderdale, FL, and Royal Palm Beach, FL
That said, BPC-157 has developed a strong underground reputation in the performance and longevity communities
Studies for which no response was received were excluded
It is believed to stimulate and elongate telomeres in human somatic cells, helping them maintain proper length